CXCR4 and neoplasm: Systemic administration of d-Arg3FC131, a CXCR4 antagonist, inhibits the growth of GH3 somatotrope tumor cell xenografts in immunodeficient nude mice by inducing apoptosis and suppressing the proliferation of tumor cells (15).